Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT

The epidemiology of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption

(2018) Alan K Davis et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors

(2017) Roland R Griffiths et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Ayahuasca: Pharmacology, neuroscience and therapeutic potential

(2016) Elisabet Domínguez-Clavé et al.   BRAIN RESEARCH BULLETIN

Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences

(2016) Theresa M Carbonaro et al.   JOURNAL OF PSYCHOPHARMACOLOGY

The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms

(2016) Frederick S Barrett et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin

(2015) Frederick S Barrett et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Dimethyltryptamine (DMT): Prevalence, user characteristics and abuse liability in a large global sample

(2013) Adam R Winstock et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

(2011) Roland R. Griffiths et al.   PSYCHOPHARMACOLOGY

Human hallucinogen research: guidelines for safety

(2008) MW Johnson et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later

(2008) RR Griffiths et al.   JOURNAL OF PSYCHOPHARMACOLOGY